How Can Healthcare Organizations Protect Connected Medical Devices from Cybersecurity Threats?
A practical guide to medical device inventories, clinical risk, manufacturer coordination, network security, and incident preparedness.
Quick Answer
Healthcare organizations can better protect connected medical devices by identifying every device and its network dependencies, evaluating cybersecurity risks in the context of patient care, restricting unnecessary network access, coordinating updates and mitigations with device manufacturers, monitoring for relevant alerts, and preparing safe incident-response procedures. Not every device can be patched, scanned, or disconnected like an ordinary computer. Clinical leadership, medical equipment specialists, IT professionals, and manufacturers must agree on changes that could affect device performance.
A practical approach follows six priorities: visibility, clinical risk assessment, network protection, manufacturer-approved maintenance, monitoring, and coordinated response. This guidance concerns organizational practices, not a claim that any single control makes a device secure.
Who This Guide Is For
Physician owners, practice administrators, operations leaders, compliance and security officers, clinical engineering contacts, and IT decision-makers at outpatient clinics, specialty practices, dental organizations, behavioral health facilities, and multi-location healthcare groups. The level of technical control available will depend on each device and its support agreement.
1. Why Connected Medical Devices Need Their Own Cybersecurity Plan
An examination room may rely on a patient monitor, ultrasound system, imaging workstation, laboratory analyzer, or other device that exchanges information with a clinical network. These technologies can improve clinical workflows, but their connections also introduce dependencies on software, credentials, vendor access, and supporting infrastructure. A disruption may affect both information security and the ability to deliver a clinical service.
A connected device is not automatically vulnerable merely because it is networked. Its risk depends on its design, configuration, exposure, clinical role, known vulnerabilities, and safeguards. Conversely, equipment that appears to function normally may still contain outdated software or unnecessary network services.
Why This Matters to Your Practice: Medical-device security decisions must account for patient safety and essential performance, not just conventional IT vulnerability scores. A technically convenient change can be inappropriate if it interrupts a clinical function.
1.1 What counts as a connected medical device?
For this guide, the term refers to a medical device or medical-device system that communicates over a network, connects to supporting software, or uses remote access for data exchange or service. Examples may include physiological monitors, infusion technologies, diagnostic imaging equipment, dental imaging systems, and certain laboratory instruments. Device classification and regulatory status depend on the particular product.
1.2 Where risks arise
| Risk area | Operational example | Question for leadership |
|---|---|---|
| Unsupported software | A critical device depends on an older operating system | What compensating controls and vendor support exist? |
| Broad network access | A device can communicate with systems it does not need | Can approved segmentation limit exposure? |
| Vendor remote access | A service account or remote tool remains persistently available | Who authorizes, monitors, and revokes access? |
| Unverified changes | A security update is installed without checking device compatibility | What manufacturer guidance and clinical approval are needed? |
| Inventory gaps | An instrument is connected without central documentation | Who owns its security review and maintenance? |
2. Responsibilities: Manufacturer, Practice, Clinical Team, and IT Provider
Medical-device cybersecurity is a shared-responsibility problem, but the participants are not interchangeable. The FDA distinguishes the manufacturer’s design and software responsibilities from the healthcare delivery organization’s responsibility to operate devices appropriately within its environment. Security work should be coordinated rather than assumed to belong entirely to one party.
| Party | Typical responsibility |
|---|---|
| Manufacturer / authorized service provider | Provide product-specific security information, advisories, supported updates, instructions, and appropriate validation of product changes. |
| Clinical leader / device owner | Determine clinical importance, patient-care implications, acceptable downtime arrangements, and clinical approval for changes. |
| Practice administration | Maintain procurement, contract, incident escalation, asset ownership, and operational communications. |
| IT / cybersecurity provider | Support approved network controls, identity and remote-access safeguards, inventory, monitoring, and technical incident coordination within contracted scope. |
| Privacy / compliance lead | Assess relevant privacy, security, contractual, and reporting obligations with qualified advice. |
Expert Tip: Before purchasing or renewing equipment, ask who will provide security advisories, how long software will be supported, whether a software bill of materials or equivalent detail is available, and what happens if a critical flaw cannot be patched.
3. The Six Essential Components of a Medical-Device Security Program
3.1 Maintain a usable device inventory
Begin with the devices that support clinically important services. Record the manufacturer, model, serial or organizational ID, physical location, clinical owner, network identifiers, installed software/firmware version when available, service provider, warranty/support status, remote-access method, and whether the device handles sensitive information. Restrict the inventory’s sensitive technical details to authorized personnel.
An inventory is only useful if it is updated when equipment is acquired, moved, serviced, retired, or replaced. Coordinate discovery with manufacturers and clinical engineering; unapproved active scanning can be unsuitable for some devices.
3.2 Prioritize risks using clinical consequences
Do not rank devices solely by whether a public vulnerability score is high. Consider exploitability and exposure alongside the consequences of losing device availability, changing its output, or compromising patient information. Device criticality and the feasibility of safe alternatives influence urgency.
| Dimension | Risk-assessment prompt |
|---|---|
| Clinical impact | What patient-care decision or service depends on this device? |
| Technical exposure | What network paths, accounts, and remote-access channels can reach it? |
| Known vulnerabilities | Are there manufacturer notices, FDA communications, or relevant advisories? |
| Mitigations | What approved network restrictions or workflow alternatives already reduce risk? |
| Recoverability | If the device is isolated, how can clinical work continue safely? |
3.3 Segment networks based on required communication
Appropriate segmentation can limit unnecessary connections between medical devices and unrelated office systems. It may include separately managed network zones and explicit rules permitting only essential communication. However, configuration must be based on documented manufacturer requirements and verified application flows; blanket blocking may break imaging transfers, remote support, or clinical integrations.
Network segmentation is not a substitute for device hardening, access management, patch planning, or monitoring. It is one layer in a broader strategy.
3.4 Control identities and vendor remote access
Identify service accounts and remote-support tools used by manufacturers or maintenance partners. Where compatible with the device and its support process, use least privilege, strong authentication, approved access windows, monitoring, and rapid revocation when personnel or vendors change. Never change manufacturer-managed credentials or authentication settings without confirming support and safety implications.
3.5 Establish an approved vulnerability and maintenance process
Subscribe to manufacturer security notices, monitor FDA safety communications and relevant vulnerability advisories, record affected device versions, and assign an owner to evaluate each notice. Confirm whether a patch is available, validated for the relevant product, and supported under the maintenance agreement. When immediate patching is unavailable, work with the manufacturer and clinical leadership on appropriate compensating controls.
A vulnerability bulletin is not by itself permission to change a medical device’s operating system, firmware, or security configuration. Changes require a controlled process and post-change functionality checks.
3.6 Prepare clinical and technical incident response
Define how staff report suspected device malfunction, unexpected network behavior, unauthorized remote access, or a device-specific advisory. The response should distinguish suspected cyber compromise from an ordinary maintenance problem and address device isolation, patient-care continuity, manufacturer notification, evidence preservation, technical containment, and safe return to service.
Why This Matters to Your Practice: A technically successful containment action may still disrupt patient care if clinicians lack an alternative workflow. Device response procedures should be rehearsed with the staff who use the equipment.
4. What to Do When a Device Cannot Be Patched
A device may run software for which no immediate supported fix exists. The appropriate response is not necessarily to disable it or install an unapproved update. Begin by verifying the device version and the manufacturer’s position; assess real exposure and clinical criticality; identify approved compensating controls; document residual risk and ownership; and establish replacement or remediation plans if the risk remains unacceptable.
| Decision | Recommended action |
|---|---|
| Manufacturer update available | Coordinate supported maintenance, clinical scheduling, validation, and documentation. |
| No approved update yet | Evaluate segmentation, restricted access, additional monitoring, and other approved compensating measures. |
| Device essential to care | Clinical leadership assesses continuity options before isolation or shutdown. |
| Support ending | Set a replacement and transition roadmap with vendor, clinical, budget, and data-migration considerations. |
| Active exploitation suspected | Activate incident-response and clinical escalation procedures promptly; obtain specialist and manufacturer guidance. |
5. Medical-Device Incident Response in Six Steps
- Identify the affected equipment, versions, connected services, and observed behavior.
- Assess immediate patient-safety implications and determine who has clinical authority.
- Contain technical exposure using approved methods coordinated with responsible specialists.
- Notify relevant vendors, IT/security, operational, and privacy personnel according to policy.
- Verify the manufacturer-supported remedy and clinical functionality before full resumption.
- Record the incident, outstanding risks, corrective actions, and future preventive changes.
These steps are an editorial operating framework. Their sequence may overlap, and urgent patient-care actions take precedence. They are not a substitute for device-specific instructions or mandatory incident reporting rules.
6. Executive Connected-Device Cybersecurity Checklist
Use the following 24-point review as a management discussion aid. A checked item should be supported by a procedure, responsible owner, or other evidence. It is not an FDA approval test or HIPAA compliance certification.
Inventory and ownership
- ☐ Critical connected devices are inventoried.
- ☐ Clinical and technical owners are assigned.
- ☐ Software and support status are documented.
- ☐ Inventory updates follow acquisition, servicing, and retirement.
Risk and clinical safety
- ☐ Device clinical criticality is assessed.
- ☐ Known exposures and vulnerabilities are reviewed.
- ☐ Clinical impacts of security changes are evaluated.
- ☐ Acceptable continuity procedures exist for critical devices.
Network and access
- ☐ Necessary network communication is documented.
- ☐ Segmentation or other boundaries are risk-based.
- ☐ Vendor remote access is authorized and reviewed.
- ☐ Accounts and credentials have assigned owners.
Maintenance and vendor coordination
- ☐ Manufacturer advisories are monitored.
- ☐ Update approval and validation responsibilities are explicit.
- ☐ Compensating controls are documented when patching is unavailable.
- ☐ Support and end-of-life dates are tracked.
Incident response
- ☐ Staff know how to report suspected device problems.
- ☐ Clinical and technical escalation contacts are current.
- ☐ Isolation decisions account for patient safety.
- ☐ Return-to-service criteria are documented.
Improvement and governance
- ☐ Device-security training is role-appropriate.
- ☐ Relevant exercises or reviews are conducted.
- ☐ Corrective actions have owners and deadlines.
- ☐ Procurement incorporates device-security questions.
Prioritize unresolved findings by potential clinical harm, likelihood of exploitation, existing controls, and feasibility of remediation; a count of completed checkboxes is not a safety rating.
7. Three-Level Connected-Device Security Maturity Model
| Level | Typical conditions | Next step |
|---|---|---|
| 1 — Reactive | Incomplete inventory, ad hoc vendor contact, unclear owners | Find clinical-critical devices, define owners, create escalation process. |
| 2 — Defined | Documented assets, access rules, advisory review, approved workflows | Test controls and exercise coordinated device response. |
| 3 — Validated | Periodic reviews, verified vendor processes, tracked remediation, tested continuity | Sustain monitoring, evaluate emerging risks, and refresh device lifecycle plans. |
Technical sophistication alone does not demonstrate maturity: clinical safeguards, manufacturer approval, and response readiness must also be reflected.
8. A Phased 90-Day Improvement Plan
The following schedule is an illustrative project plan, not a legal or clinical deadline. Immediate safety concerns must be escalated without waiting for a planned phase.
| Period | Management priorities | Output |
|---|---|---|
| Days 1–15 | Identify clinical-critical devices, owners, vendor contracts, and known advisories. | Baseline inventory and highest-risk gaps. |
| Days 16–35 | Map required connections and vendor access; review clinical dependencies. | Approved risk register and responsibility map. |
| Days 36–60 | Implement approved high-priority measures and practice a tabletop scenario. | Change records, exercise notes, corrective actions. |
| Days 61–90 | Verify controls, assign lifecycle replacements, establish ongoing monitoring. | Management dashboard and next review schedule. |
9. Practical Healthcare Scenario: A Connected Patient Monitor Requires Security Review
Consider a Los Angeles outpatient specialty clinic using network-connected patient monitors. The clinical team receives a manufacturer security advisory affecting a device model deployed in several examination areas. IT identifies the network locations of the affected equipment, while the practice administrator confirms which clinicians and appointments depend on the monitors.
Rather than installing an unverified patch or disconnecting every monitor, the practice asks the manufacturer to confirm affected versions and recommended mitigations. Clinical leadership determines whether any service adjustments or alternate equipment are necessary. Technical personnel review approved segmentation and remote-access restrictions, then document how controls can be implemented without interrupting required data transmission.
After the approved changes, designated personnel verify device functions and connected workflows. Remaining exposures receive named owners and follow-up dates. The central lesson is that medical-device cybersecurity must coordinate technical containment with device performance and patient-care needs.
10. Executive Performance Indicators
| KPI | How to assess | Suggested owner |
|---|---|---|
| Inventory completeness | Known in-scope devices with validated records / estimated in-scope inventory | IT + clinical device owner |
| Advisory review timeliness | Elapsed time from relevant notice identification to documented triage | Security lead |
| Vendor access review | Approved active access arrangements / total identified arrangements | IT / vendor coordinator |
| Mitigation closure | Priority actions verified complete by target date / actions due | Operations + technical owner |
| End-of-support planning | Critical devices with lifecycle plan / devices nearing support end | Practice administrator |
| Response exercise coverage | Relevant device scenarios exercised / planned scenarios | Clinical + operations leaders |
A useful dashboard also includes assigned owner, organization-specific target, observed result, status, and corrective action. Avoid unsupported generic benchmark percentages or fabricated performance histories.
11. Frequently Asked Questions
Are connected medical devices more vulnerable than ordinary computers?
Not necessarily. Their risk is different because clinical availability, specialized software, long support lifecycles, and manufacturer-controlled changes can limit familiar IT mitigation options.
Should our practice scan every device for vulnerabilities?
Not without a device-aware process. Some active methods can disrupt sensitive equipment; coordinate discovery and testing with authorized technical personnel and manufacturer guidance.
Can an IT provider install any available device security patch?
No. Confirm manufacturer-supported updates, the maintenance agreement, and clinical validation needs before making changes.
What is network segmentation for medical devices?
It is the use of controlled network boundaries and rules to limit unnecessary device communication while preserving required clinical interfaces and vendor support.
Who handles cybersecurity for devices supplied by a vendor?
Responsibility is shared and contract-specific. Manufacturers address product issues; healthcare organizations manage deployment and clinical use; IT supports approved environmental controls.
What if a device is no longer supported?
Evaluate clinical importance, exposure, compensating controls, and an appropriate replacement timeline with the manufacturer and clinical leaders.
Does HIPAA require a specific medical-device security checklist?
No universal 24-point checklist is prescribed. Applicable HIPAA Security Rule requirements and risk-based safeguards must be assessed separately.
How should a clinic respond to a device vulnerability warning?
Verify affected versions, assess clinical and technical risk, contact the manufacturer, implement approved mitigations, and document remaining actions.
Does FDA clearance mean a device will never have security vulnerabilities?
No. Cybersecurity is a lifecycle issue; manufacturers and healthcare organizations must continue managing new vulnerabilities and operating risks.
12. Five Executive Priorities
- Know which devices are connected, where they operate, and who owns them.
- Evaluate cybersecurity choices against patient safety and essential device performance.
- Coordinate product changes with the manufacturer and clinical leadership.
- Limit unnecessary network and vendor access using approved safeguards.
- Maintain an advisory, incident-response, and device lifecycle improvement process.
13. How Fothion Helps
Healthcare organizations often need coordinated assistance with the infrastructure surrounding connected medical equipment. Within an agreed engagement, Fothion can support network and endpoint assessments, documented connectivity and access controls, technical vendor coordination, cybersecurity planning, and infrastructure improvement decisions. Clinical leaders and device manufacturers remain responsible for device-specific clinical and manufacturer-controlled decisions.
A device-security review can also inform a broader healthcare IT assessment and technology roadmap: which network boundaries need attention, which access arrangements are unclear, and which aging technology may require coordinated replacement.
Is Your Healthcare Network Ready for Connected Medical Devices?
If your practice relies on network-connected diagnostic or monitoring technology, understanding its supporting infrastructure is an important step toward safer, more resilient operations. Speak with Fothion about reviewing the technology environment and vendor coordination supporting your medical practice.
Explore More Healthcare Industry Insights
- Healthcare Cybersecurity Checklist: Essential Security Controls Every Medical Practice Should Have
- What Is a Healthcare IT Assessment and Why Does Your Medical Practice Need One?
- Technology Policies Every Medical and Dental Practice Should Have
- How to Choose the Right IT Provider for Your Medical or Dental Practice
- Why Healthcare Organizations Need a Technology Roadmap (And How to Build One)
About This Guide and Educational Disclaimer
This Healthcare IT Industry Insights guide supports executive understanding of connected-device cybersecurity and the responsibilities that surround clinical technology. It is educational content, not medical, legal, regulatory, device-maintenance, or patient-specific advice. Practices should follow applicable requirements, manufacturer instructions, clinical governance, and qualified technical and compliance guidance. Original frameworks are not official FDA, HHS, or CISA certification tools.
Final Thoughts
Medical-device cybersecurity is strongest when healthcare organizations know what equipment they use, understand which services depend on it, and coordinate protection with the people responsible for patient care and device performance. Visibility, approved network controls, manufacturer engagement, and practiced response procedures help protect both the technology environment and the clinical work it supports.
Authoritative References
- FDA — Cybersecurity in Medical Devices (program overview)
- FDA — Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions (February 2026)
- FDA — Postmarket Management of Cybersecurity in Medical Devices
- HHS — Healthcare and Public Health Cybersecurity Performance Goals
- CISA — Healthcare and Public Health Sector Mitigation Guide
Leave a Comment